Allopurinol EP Impurity B
✓
데이터 정확도 100%
연중무휴 과학적 지원
⬡
제품 품질에 대한 무관용 원칙

재고 위치

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

22407-20-1Allopurinol EP Impurity B

● 재고 있음

카탈로그 번호:VL1430002
CAS 번호:22407-20-1
분자식:C5H6N4O2
분자량:154.13 g/mol

에 대한 추가 정보 CAS 22407-20-1

모약물

Allopurinol

IUPAC명

5-(formylamino)-1H-pyrazole-4-carboxamide

약전 동의어

Allopurinol Related Compound B

Other Synonyms

3-Formamidopyrazole-4-carboxamide ;1H-Pyrazole-4-carboxamide, 3-(formylamino)

SMILES

O=C(C1=C(NC=O)NN=C1)N

InChI

InChI=1S/C5H6N4O2/c6-4(11)3-1-8-9-5(3)7-2-10/h1-2H,(H2,6,11)(H2,7,8,9,10)

설명

Allopurinol EP Impurity B also known in pharmacopoeias as Allopurinol Related Compound B is a thoroughly characterized reference standard. It meets strict regulatory standards including those set by USP EMA JP and BP. This product is crucial for use in Abbreviated New Drug Applications (ANDA) New Drug Applications (NDA) and the commercial production of Acyclovir . Additionally it comes with a detailed Structure Elucidation Report (SER) ensuring its precision and dependability for a variety of analytical uses. Allopurinol EP Impurity B (CAS No: 22407-20-1) or Allopurinol Related Compound B/5-(formylamino)-1H-pyrazole-4-carboxamide is an impurity formed during the synthesis of Allopurinol that is an oxypurine base used as a first-choice drug in the management of primary and secondary hyperuricemia.

References

Murrell, G. A. C., and W. G. Rapeport. “Clinical Pharmacokinetics of Allopurinol.” Clinical Pharmacokinetics, vol. 11, no. 5, 1986, pp. 343–53, https://doi.org/10.2165/00003088-198611050-00001. Osabe, Makoto, et al. “In Silico Analysis of Interactions between HLA-B*58:01 and Allopurinol-Related Compounds.” Chem-Bio Informatics Journal, vol. 16, no. 0, 2016, pp. 1–4, https://doi.org/10.1273/cbij.16.1. ‌

견적 요청

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url